Target and Pathway |
Top |
Target(s) |
5-HT 1A receptor (HTR1A) |
Target Info
|
Antagonist |
[1] |
5-HT 2A receptor (HTR2A) |
Target Info
|
Antagonist |
[1] |
Adrenergic receptor alpha-1A (ADRA1A) |
Target Info
|
Antagonist |
[1] |
Adrenergic receptor alpha-1D (ADRA1D) |
Target Info
|
Antagonist |
[1] |
Target's Patent Info |
5-HT 1A receptor (HTR1A) |
Target's Patent Info
|
[1] |
5-HT 2A receptor (HTR2A) |
Target's Patent Info
|
[1] |
Adrenergic receptor alpha-1A (ADRA1A) |
Target's Patent Info
|
[1] |
Adrenergic receptor alpha-1D (ADRA1D) |
Target's Patent Info
|
[1] |
KEGG Pathway
|
Calcium signaling pathway
|
Neuroactive ligand-receptor interaction
|
Gap junction
|
Serotonergic synapse
|
Inflammatory mediator regulation of TRP channels
|
cGMP-PKG signaling pathway
|
AMPK signaling pathway
|
Adrenergic signaling in cardiomyocytes
|
Vascular smooth muscle contraction
|
Salivary secretion
|
cAMP signaling pathway
|
NetPath Pathway
|
IL2 Signaling Pathway
|
Panther Pathway
|
5HT2 type receptor mediated signaling pathway
|
Alpha adrenergic receptor signaling pathway
|
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
5HT1 type receptor mediated signaling pathway
|
Reactome
|
Serotonin receptors
|
G alpha (q) signalling events
|
Adrenoceptors
|
G alpha (12/13) signalling events
|
G alpha (i) signalling events
|
WikiPathways
|
Serotonin Receptor 2 and STAT3 Signaling
|
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
|
SIDS Susceptibility Pathways
|
Monoamine GPCRs
|
GPCRs, Class A Rhodopsin-like
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
GPCR ligand binding
|
GPCR downstream signaling
|
GPCRs, Other
|
Calcium Regulation in the Cardiac Cell
|
Endothelin Pathways
|
AMPK Signaling
|
Serotonin HTR1 Group and FOS Pathway
|